Antitrust enforcement is likely to return to its established norms, Jay Ezrielev writes in a guest commentary.

The Federal Trade Commission (FTC) under Chair Lina Khan took an aggressive approach to tackling anticompetitive behavior in ...

NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

in the US for operating a "perverse drug rebate system" that it claims artificially inflated the prices of insulin products. The lawsuit – which has been anticipated since the FTC published a ...

Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

and CVS Caremark – over alleged anti-competitive practices that have driven up insulin costs. The FTC is reported to be preparing its own lawsuit against the top companies in the sector ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

With President-elect Donald Trump returning to the White House, a changing of the guard at the Federal Trade Commission (FTC) ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and ...